title: RETRACTED: Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.
abstract: This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal).
  
  This article has been retracted at the request of This article has been retracted at the request of the authors and the Editor-in-Chief.
  
  The authors contacted the Editors of the European Journal of Cancer regarding oversights or labelling errors introduced in Fig. 2 and Fig.7 during data processing. The authors provided the raw data, however the Editors conclude that the raw data management cannot be relied upon and the article needs to be retracted.
authors.affiliation: State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun 130012, PR China.
authors.forename: Tingting
authors.initials: T
authors.lastname: Lin
authors.forename: Zhiying
authors.initials: Z
authors.lastname: Ding
authors.forename: Nan
authors.initials: N
authors.lastname: Li
authors.forename: Jiayun
authors.initials: J
authors.lastname: Xu
authors.forename: Guimin
authors.initials: G
authors.lastname: Luo
authors.forename: Junqiu
authors.initials: J
authors.lastname: Liu
authors.forename: Jiacong
authors.initials: J
authors.lastname: Shen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D015153:Blotting, Western; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D020169:Caspases / Q000378:metabolism; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D005434:Flow Cytometry; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors*; D016566:Organoselenium Compounds / Q000494:pharmacology*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D034741:RNA, Small Interfering / Q000378:metabolism; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism*; D014183:Transplantation, Heterologous; D047392:beta-Cyclodextrins / Q000494:pharmacology*; D001616:beta-Galactosidase / Q000378:metabolism
chemical_list: C500959:2-selenium-bridged beta-cyclodextrin; D000970:Antineoplastic Agents; D016328:NF-kappa B; D016566:Organoselenium Compounds; D034741:RNA, Small Interfering; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D011994:Recombinant Proteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D047392:beta-Cyclodextrins; D008156:Luciferases; D011065:Poly(ADP-ribose) Polymerases; D001616:beta-Galactosidase; D020169:Caspases